Skip to content
Review

Type 2 Diabetes Mellitus: Interplay Among Biological, Environmental, and Socioeconomic Determinants in Disease Progression and Management.

Sep 2026 · Current Medicinal Chemistry · 0 citations
Medicine

TL;DR

T2DM arises from metabolic alterations driven by environmental and socioeconomic factors that can modify disease susceptibility and clinical evolution, and the persistent global increase in T2DM highlights the need for preventive and therapeutic strategies that extend beyond glycemic control alone.

Abstract

Background

Type 2 Diabetes Mellitus (T2DM) is a complex metabolic disorder characterized by insulin resistance and progressive β-cell dysfunction, although these mechanisms alone do not account for the considerable variability observed in disease presentation and clinical evolution. During the last decade, epidemiological and mechanistic studies have shown that metabolic dysfunction develops within a broader framework in which biological susceptibility is continuously shaped by environmental exposures, occupational conditions, lifestyle-related behaviors, psychosocial influences, and socioeconomic circumstances. Rather than acting independently, these factors appear to modify metabolic regulation through interconnected biological pathways that contribute to differences in disease susceptibility, progression, and long-term outcomes across populations. This perspective supports a more integrated interpretation of T2DM pathophysiology, in which biological, environmental, and socioeconomic influences jointly determine disease expression. Accordingly, this review critically evaluates current evidence regarding the contribution of these interacting determinants to the onset, progression, and clinical manifestations of T2DM.

Methods

This narrative review was based on publications retrieved from PubMed, Scopus, and Web of Science addressing biological, environmental, behavioral, occupational, and socioeconomic factors relevant to T2DM. Epidemiological, clinical, and experimental studies were selected to provide complementary evidence on the mechanisms through which these variables contribute to metabolic dysfunction, disease progression, and diabetes-related complications. Particular attention was given to investigations examining the interplay among these factors rather than considering them as isolated contributors to disease development.

Results

The literature examined indicates that T2DM arises through the convergence of multiple pathogenic processes rather than from a single metabolic abnormality. Obesity, insulin resistance, sedentary lifestyles, and dietary imbalance remain central contributors to disease development, while increasing evidence also points to a relevant contribution from environmental exposures and socioeconomic conditions. Pollutants, adverse occupational settings, chronic psychosocial stress, and inequalities in healthcare access have all been associated with disturbances in metabolic regulation and less favorable clinical outcomes. Delayed diagnosis, limited preventive strategies, and insufficient diabetes education further compromise long-term disease management and may contribute to the persistence of chronic complications.

Discussion

T2DM arises from metabolic alterations driven by environmental and socioeconomic factors that can modify disease susceptibility and clinical evolution. Differences in disease burden observed across populations are unlikely to result from isolated determinants; instead, they appear to reflect the cumulative influence of environmental exposures, social conditions, and biological vulnerability. Their combined effects may promote chronic inflammation, oxidative stress, and progressive impairment of glucose homeostasis, although the relative contribution of each determinant probably differs according to the characteristics of the population studied.

Conclusion

The persistent global increase in T2DM highlights the need for preventive and therapeutic strategies that extend beyond glycemic control alone. Addressing environmental exposures, socioeconomic inequalities, healthcare accessibility, and lifestyle-related factors alongside conventional metabolic management may improve long-term clinical outcomes and reduce the burden of diabetes-related complications. A broader understanding of how these determinants interact will also facilitate the development of more effective public health policies and individualized therapeutic approaches.

View source

Similar papers

Review Open access Sep 2026

Type 2 diabetes mellitus: emerging mechanistic insights, evolving therapeutic strategies, and future perspectives

This review synthesizes contemporary mechanistic insights, evolving therapeutic approaches, and future directions in T2DM management, highlighting opportunities for personalized care and improved long-term outcomes.

Himanshu, Suryakant Verma, Sonam Yadav et al. · 0 citations
Review Open access Aug 2026

Prediabetes: diagnostic aspects, clinical features, and emerging therapeutic opportunities, with a focus on Vitamin D.

BACKGROUND Prediabetes is a highly prevalent and heterogeneous condition associated with an increased risk of type 2 diabetes mellitus (T2DM), cardiovascular disease, and other cardiometabolic complications. Growing evidence suggests a potential role of vitamin D in glucose metabolism and diabetes prevention. OBJECTI...

G. Aimaretti, A. Avogaro, R. Buzzetti et al. · 0 citations
Review Open access Aug 2026

Psoriasis and type 2 diabetes mellitus: epidemiology, shared mechanisms, and therapeutic implications: a narrative review

Psoriasis is a chronic immune-mediated inflammatory disorder increasingly recognized as a systemic disease rather than an isolated cutaneous condition. In addition to its dermatologic burden, psoriasis is associated with multiple metabolic comorbidities, among which type 2 diabetes mellitus (T2DM) is particularly impor...

Amr Molla · 0 citations
Review Open access Jan 2026

Is Insulin Resistance the Driver or the Outcome of Diabetes Mellitus? A Critical Review

This study seeks to clarify the causal relationship between IR and DM by integrating mechanistic insights, clinical data, and recent epidemiological studies to critically evaluate whether IR is a cause, an effect, or both in the pathogenesis of DM.

Shafay Shahid, Saadia Qamar, Fouzia Qamar et al. · 0 citations
Review Open access Sep 2026

Type 1 diabetes in the era of obesity: Pathophysiology and therapeutic implications

This review summarizes the epidemiology, pathophysiology, clinical consequences, and therapeutic implications of insulin‐resistant type 1 diabetes, reviewing the established precedent of amylin replacement and potential treatments including incretin receptor agonists and next‐generation amylin receptor agonists.

Z. Bloomgarden · 0 citations
Open access Aug 2026

The Complex Interplay Between Dyslipidemic Subjects Living with Type 2 Diabetes and Metabolic Syndrome and Statin Treatment: A Reflection on Adherence and Persistence in the Real World

High levels of blood cholesterol are a major risk factor for atherosclerotic cardiovascular disease and require early and consistent utilization of statins as first-line medications to avoid disabling or even deadly consequences. Nevertheless, real-world treatment adherence is significantly lower than that reported in...

F. Strollo, G. Guarino, Ersilia Satta et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.